Table
of Contents
|
|
|
|
|
|
Introduction to the Continuing Education (CE) Contact Hour Application
Process |
v |
|
Chapter 1 |
Taking the Certification Examination |
1 |
|
|
General Suggestions for Preparing for the Exam |
|
|
|
About the Certification Exams |
|
|
Chapter 2 |
Ethical and Legal Issues |
9 |
|
|
Ethics |
|
|
|
Ethical Principles |
|
|
|
Regulation of Nursing Practice |
|
|
|
Legal Aspects |
|
|
Chapter 3 |
Theory: Nursing and Health |
21 |
|
|
General Comments Regarding Theory |
|
|
|
Nursing Theory |
|
|
|
Human Behavior |
|
|
|
Community-Level Behavior Change |
|
|
|
Organizational Change |
|
|
|
Family Dynamics |
|
|
|
Crisis Theory |
|
|
Chapter 4 |
Leadership |
33 |
|
|
Leadership |
|
|
|
|
|
|
|
Case Management |
|
|
|
Total Quality Management |
|
|
|
Continuous Quality Improvement |
|
|
|
Outcome Evaluation |
|
|
|
Program Certification |
|
|
|
Magnet Recognition Program |
|
|
Chapter 5 |
Research |
43 |
|
|
Problem Identification |
|
|
|
Research Method |
|
|
|
Qualitative Methods |
|
|
|
Ensuring Trustworthiness |
|
|
|
Quantitative Methods |
|
|
|
Data Collection Strategies |
|
|
|
Protection of Human Rights |
|
|
|
Data Analysis |
|
|
|
Evidence-Based Practice |
|
|
|
Outcomes Evaluation |
|
|
Chapter 6 |
Communication, Education, and Counseling |
59 |
|
|
Communication |
|
|
|
Patient Education and Adult Learning |
|
|
|
Patient Education Process |
|
|
|
Patient Education and Counseling |
|
|
|
Health Self-Management |
|
|
|
Discharge Planning |
|
|
Chapter 7 |
Cardiac and Vascular Risk |
77 |
|
|
Coronary Heart Disease |
|
|
|
Stroke |
|
|
|
Peripheral Vascular Disease |
|
|
|
Overall Cardiac and Vascular Risk |
|
|
Chapter 8 |
Risk Reduction |
93 |
|
|
Levels of Prevention |
|
|
|
Cardiovascular Disease Prevention |
|
|
|
Tobacco Use and Exposure |
|
|
|
Nutrition |
|
|
|
Exercise and Activity |
|
|
|
Cardiac Rehabilitation |
|
|
Chapter 9 |
Hypertension Management |
107 |
|
|
Normal Blood Pressure |
|
|
|
Regulation of Blood Pressure |
|
|
|
Hypertension |
|
|
|
Sleep Apnea and Hypertension |
|
|
|
Clinical Assessment with Hypertension |
|
|
|
Management of Hypertension |
|
|
Chapter 10 |
Dyslipidemia Management |
123 |
|
|
Understanding Lipoprotein Structure, Function, and Metabolism |
|
|
|
Hyperlipidemia |
|
|
|
Screening for Atherosclerosis Risk |
|
|
|
ATP III Guidelines |
|
|
|
Implications for Nursing Practice |
|
|
|
Treatment of Dyslipidemia |
|
|
|
Metabolic Syndrome |
|
|
|
New Approaches to Lipid Assessment |
|
|
Chapter 11 |
Pathophysiologic Processes |
135 |
|
|
Pathophysiologic Stimuli |
|
|
|
Cellular Structure and Function |
|
|
|
Cellular Injury and Death |
|
|
|
Vascular Structure and Function |
|
|
|
Cardiac Structure and Function |
|
|
|
Cardiac Muscle Cells |
|
|
|
Cerebral Circulation |
|
|
|
Vascular Cell Response to Injury |
|
|
|
Hypoxia and Ischemia |
|
|
|
Inflammation |
|
|
|
Atherosclerosis |
|
|
|
Thrombosis and Embolism |
|
|
|
Altered Vascular Function |
|
|
|
Altered Cardiac Function |
|
|
Chapter 12 |
Cardiac and Vascular Assessment |
163 |
|
|
Basic Principles |
|
|
|
Subjective Information (History) |
|
|
|
Physical Examination |
|
|
|
Diagnostic Tests |
|
|
|
Laboratory Tests Using Blood |
|
|
|
Noninvasive Diagnostic Testing |
|
|
|
Diagnostic Ultrasonography |
|
|
|
Diagnostic Testing Using Radionuclides |
|
|
|
Invasive Diagnostic Testing |
|
|
Chapter 13 |
Cardiac and Vascular Disease Manifestations |
201 |
|
|
Angina Pectoris |
|
|
|
Myocardial Infarction |
|
|
|
Valvular Heart Disease |
|
|
|
Mitral Stenosis |
|
|
|
Mitral Regurgitation |
|
|
|
Aortic Stenosis |
|
|
|
Aortic Regurgitation |
|
|
|
Infective Endocarditis |
|
|
|
Acute Pericarditis |
|
|
|
Dilated Congestive Cardiomyopathy |
|
|
|
Hypertrophic Cardiomyopathy |
|
|
|
Restrictive Cardiomyopathy |
|
|
|
Heart Failure |
|
|
|
Atrial Fibrillation |
|
|
|
Atrial Flutter |
|
|
|
First-Degree Atrioventricular Block |
|
|
|
Second-Degree Atrioventricular Block
Type I |
|
|
|
Second-Degree Atrioventricular Block
Type II |
|
|
|
Third-Degree Atrioventricular Block,
Complete Heart Block |
|
|
|
Ventricular Tachycardia |
|
|
|
Ventricular Fibrillation |
|
|
|
Sudden Cardiac Death |
|
|
|
Pulmonary Artery Hypertension |
|
|
|
Carotid Artery Occlusive Disease |
|
|
|
Acute Management of Thrombotic CVA |
|
|
|
Abdominal Aortic Aneurysm |
|
|
|
Upper Extremity Arterial Occlusive Disease |
|
|
|
Lower Extremity Arterial Occlusive Disease |
|
|
|
Deep Vein Thrombosis |
|
|
|
Chronic Venous Insufficiency |
|
|
Chapter 14 |
Invasive Management of Cardiac and Vascular Disease |
273 |
|
|
Percutaneous Coronary
Intervention |
|
|
|
Coronary Atherectomy |
|
|
|
Percutaneous Transluminal Angioplasty of the Lower Extremity |
|
|
|
Percutaneous Transluminal Angioplasty of the Carotid Artery |
|
|
|
Percutaneous Transluminal Angioplasty of the Renal Artery |
|
|
|
Percutaneous Balloon Valvuloplasty |
|
|
|
Pacemakers |
|
|
|
Implantable Cardioverter Defibrillator |
|
|
|
Coronary Artery Bypass Graft Surgery |
|
|
|
Valvular Repair and Valvular
Replacement |
|
|
|
Arterial Bypass Surgery |
|
|
|
Aneurysm Repair |
|
|
|
Carotid Endarterectomy |
|
|
|
Peripheral Thromboembolectomy |
|
|
|
Overview of Cardiac Transplantation |
|
|
Chapter 15 |
Cardiovascular Pharmacology |
317 |
|
|
Adrenergic Group |
|
|
|
Inotropic Agents |
|
|
|
Antidysrhythmics |
|
|
|
Vasodilators |
|
|
|
Calcium Channel Blockers |
|
|
|
Drugs Influencing the Renin-Angiotensin-Aldosterone
System |
|
|
|
Diuretics |
|
|
|
Anticoagulant, Antithrombotic, and Thrombolytic Drugs |
|
|
|
Antihyperlipidemics |
|
|
|
Other Approaches to Hyperlipidemia |
|
|
Chapter 16 |
Special Situations |
355 |
|
|
Emergency Conditions |
|
|
|
Acute Heart Failure and Pulmonary Edema |
|
|
|
Race, Ethnic, Gender, and Cultural Considerations |
|
|
|
Comorbid or Concomitant Conditions |
|
|
|
Specific Nursing Interventions |
|
|
Chapter 17 |
Psychosocial Aspects |
371 |
|
|
Coping and Adaptation |
|
|
|
Quality of Life |
|
|
Appendix A |
Review Questions |
381 |
|
Appendix B |
Answers to the Review Questions |
391 |
|
|
Index |
397 |
|
|
About the Author |
409 |
|
|
|
|